100 investors to watch 2026 100 investors to watch 2026 100 investors to watch 2026
Friday 20 November, 2026
[email protected]
Resilience Media
  • News
    • Events
    • Interview
    • Startups
    • Venture
    • Weekly Digest
  • Resilience Conference
    • Resilience Conference London — Oct 2026
    • Resilience Conference Copenhagen — May 2026 (PAST)
    • Resilience Conference Warsaw — Apr 2026 (PAST)
  • Launch
  • About
  • Guest Posts
    • Author a Post
  • Subscribe
No Result
View All Result
  • News
    • Events
    • Interview
    • Startups
    • Venture
    • Weekly Digest
  • Resilience Conference
    • Resilience Conference London — Oct 2026
    • Resilience Conference Copenhagen — May 2026 (PAST)
    • Resilience Conference Warsaw — Apr 2026 (PAST)
  • Launch
  • About
  • Guest Posts
    • Author a Post
  • Subscribe
No Result
View All Result
Resilience Media
No Result
View All Result

USIL Therapeutics passes initial NATO procurement assessment as it develops radiation exposure treatments

The Luxembourg-based startup moves closer to NATO procurement eligibility as European defence planners face growing nuclear and radiological threats.

John BiggsbyJohn Biggs
November 20, 2026
in Dual-Use Technology, NATO, News, Resilience Conference, Startups
Share on Linkedin

Luxembourg-based USIL Therapeutics has passed the initial vendor registration assessment of the NATO Support and Procurement Agency (NSPA), giving the dual-use defence company a potential route into NATO’s defence procurement system.

You Might Also Like

Auterion and SkyFall plan German drone factory to boost Ukrainian production

Michigan wants to turn its automotive manufacturing power into a defence industry advantage

Atmos and MBDA link up to give Europe deep strike capability from space

The company participated in Resilience’s LAUNCH cohort at the Resilience conference in London this year.

Founded just over a year ago, the company is developing countermeasures for acute radiation syndrome (ARS), a potentially fatal condition caused by exposure to high doses of ionising radiation. Their products include an IV solution and a standalone injector for emergency use.

The NSPA has confirmed that USIL Therapeutics meets its initial registration requirements and will establish a procurement account for the company. This will allow it to access the agency’s procurement platform and participate in Request for Proposal (RFP) processes. Full registration remains subject to a Declaration of Eligibility from the relevant national authorities. Once that declaration is received, the company will be cleared to conduct business with the NSPA.

“For a company at our stage, reaching this point in the NATO procurement process is an important achievement and a significant opportunity,” said Fred Marin, CEO of USIL Therapeutics. “It allows us to take the next steps towards working with defence and security organisations that recognise the importance of medical preparedness for nuclear and radiological emergencies.”

The assessment is notable given the company’s age and lack of an established record of government procurement contracts. However, registration does not constitute a NATO contract or an endorsement of the company’s treatments. It establishes a potential route to future procurement opportunities.

USIL Therapeutics is developing treatments for acute radiation syndrome, which can occur following exposure to high levels of ionising radiation. The condition can severely damage the bone marrow, gastrointestinal system and other organs, with potentially fatal consequences.

The company’s work addresses a part of defence preparedness that receives less attention than conventional weapons, air defence systems and battlefield technology.

The war in Ukraine has increased concerns about nuclear escalation and the safety of nuclear facilities in conflict zones. The risk of radiological incidents has also raised questions about whether European governments have sufficient medical resources to respond to large-scale radiation exposure.

While iodine tablets can protect the thyroid against radioactive iodine under specific circumstances, they do not treat acute radiation syndrome. Severe radiation exposure requires different medical interventions, making the development of additional treatments an important area of research.

The company said it will continue developing its medical countermeasures while pursuing the remaining steps in the NSPA registration process.

Its progress also reflects a broader question facing European defence planners: whether existing medical systems are adequately prepared for the consequences of nuclear and radiological incidents, and whether emerging biotechnology companies can help close those gaps.

Tags: pharmaradiationUkraineusil
Previous Post

Auterion and SkyFall plan German drone factory to boost Ukrainian production

John Biggs

John Biggs

John Biggs is an entrepreneur, consultant, writer, and maker. He spent fifteen years as an editor for Gizmodo, CrunchGear, and TechCrunch and has a deep background in hardware startups, 3D printing, and blockchain. His work has also appeared in Men’s Health, Wired, and the New York Times. He has written nine books including the best book on blogging, Bloggers Boot Camp, and a book about the most expensive timepiece ever made, Marie Antoinette’s Watch. He lives in Brooklyn, New York. He runs the Keep Going podcast, a podcast about failure. His goal is to share how even the most confident and successful people had to face adversity.

Related News

Auterion, the drone software startup, eyes raising $200M at a $1.2B+ valuation

Auterion and SkyFall plan German drone factory to boost Ukrainian production

byCarly Page
November 20, 2026

Auterion and Ukrainian drone manufacturer SkyFall are planning to establish a joint venture in Germany to increase production of first-person...

Michigan wants to turn its automotive manufacturing power into a defence industry advantage

Michigan wants to turn its automotive manufacturing power into a defence industry advantage

byJohn Biggs
November 20, 2026

  Michigan has spent decades building cars, trucks and industrial equipment. Now the state wants to use that manufacturing capacity...

Atmos space cargo visual

Atmos and MBDA link up to give Europe deep strike capability from space

byPaul Sawers
November 18, 2026

The ability to transport payloads into orbit and return them to precise locations on Earth could give European armed forces...

‘We are using it all’: minister talks about how Ukraine is offsetting Starlink dependency

‘We are using it all’: minister talks about how Ukraine is offsetting Starlink dependency

byIngrid Lunden
November 18, 2026

This week, NATO’s Communications and Information Agency announced during the NATO Edge conference that it was unlocking procurement totalling a...

An ‘optimistic’ Alexander Stubb talks war and peace at Slush

An ‘optimistic’ Alexander Stubb talks war and peace at Slush

byFiona Alston
November 18, 2026

Finland's President Alexander Stubb opened the Slush tech conference in Helsinki by touching on AI, European sovereignty, and a bleak...

Tekever raises $580M at a $6.8B valuation to give flight to more drones

Tekever’s €200 million France plan: new factory, contract with French army

byStanislaw Naklicki
November 17, 2026

In the 1960s and 1970s, Portugal’s workers would migrate to France for manufacturing jobs. Half a century later, the Portuguese...

Satellites become a growing target for grey-zone warfare

ICEYE lights a rocket under its satellite business, offers €2.05B for launcher company Avio

byLuke Smithand1 others
November 17, 2026

Some consolidation is taking place in the space race. Finland-based satellite maker/operator ICEYE has made an offer to buy Avio,...

OpenAI, facing a cybersecurity lawsuit in the US, is working with NATO… on cybersecurity

OpenAI, facing a cybersecurity lawsuit in the US, is working with NATO… on cybersecurity

byIngrid Lunden
November 17, 2026

OpenAI's allegedly lacklustre approach to security and safeguarding across has just landed the AI giant a major lawsuit in California,...

Load More

Top stories

Tiberius says it’s successfully tested Sceptre munitions that behave like more costly missiles
European Defence

Tiberius, the munitions startup, becomes the latest defence tech unicorn, raising $85M at a $1B valuation

November 16, 2026
Quantum Systems Raises €160M to Expand AI Drone Production
Cyber

Quantum Systems hit by cyberattack, prompting drone grounding

November 13, 2026
Helsing launches Clarity, a competitor to Palantir’s Maven
European Defence

Helsing launches Clarity, a competitor to Palantir’s Maven

November 11, 2026
Atmos space cargo visual
European Defence

Atmos and MBDA link up to give Europe deep strike capability from space

November 18, 2026

Resilience Media is an independent publication covering the future of defence, security, and resilience. Our reporting focuses on emerging technologies, strategic threats, and the growing role of startups and investors in the defence of democracy.

  • About
  • News
  • Resilence Conference
    • Resilience Conference Copenhagen 2026
    • Resilience Conference Warsaw 2026
  • Guest Posts
  • Subscribe
  • Privacy Policy
  • Terms & Conditions
  • Mission Statement & Code of Practice
  • Press

© 2026 Resilience Media

No Result
View All Result
  • Home
  • About
  • Subscribe
  • Events
  • Guest Posts
  • Interview
  • News
  • Resilience Conference London 2026
  • Resilience Conference Copenhagen 2026
  • Resilience Conference Warsaw 2026

© 2026 Resilience Media

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.